AgNovos Bioscience
Business Services · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7301 Calhoun Pl Ste 100, Rockville, Mary...Phone Number
(609) 319-2664Website
www.agnovos.comRevenue
$11.3 MillionIndustry
About AgNovos Bioscience
AgNovos Bioscience Org Chart
Is AgNovos Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once AgNovos Bioscience has new funding data
Click to see if AgNovos Bioscience had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at AgNovos Bioscience
Product Launch: Get notified when AgNovos Bioscience launches new products
Earning: See what the market has to say on AgNovos Bioscience recently announced quarterly report
AgNovos Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if AgNovos Bioscience is spiking on competitors!
Check if AgNovos Bioscience has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at AgNovos Bioscience
Find more new buyers
Compare Similar Companies to AgNovos Bioscience
Compare insights from companies similar to AgNovos Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AgNovos Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AgNovos Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AgNovos Bioscience.
AgNovos Bioscience financials insights
Gather financial insights about AgNovos Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$350K
AgNovos Bioscience Tech Stack
A closer look at the technologies used by AgNovos Bioscience
Most Recent Scoops
AgNovos Bioscience News & Media
AgNovos Healthcare vollendet die Patientenrekrutierung in die klinische Studie CONFIRM
NEW YORK--(BUSINESS WIRE)--AgNovos Healthcare, ein Unternehmen, das mit Hilfe einer firmeneigenen Knochenaufbau-Technologie und regenerativer Medizin neue Therapien zur Behandlung von Knochenerkrankungen entwickelt, gab heute bekannt, dass es die Patientenrekrutierung in seine Studie CONFIRM abgeschlossen hat. Die CONFIRM-Studie soll zusätzliche Daten zur Sicherheit und Wirksamkeit des von AgNovos Healthcare entwickelten Produktes AGN1 Local Osteo-Enhancement Procedure (LOEP) zur Anwendung beiAgNovos Healthcare achève le recrutement pour l'étude clinique CONFIRM
NEW YORK--(BUSINESS WIRE)--AgNovos Healthcare, un développeur de nouvelles thérapies reposant sur une technologie propriétaire de construction osseuse et sur la médecine régénérative pour répondre à des besoins non satisfaits dans le traitement des maladies osseuses, a annoncé aujourd'hui la fin du recrutement pour son étude CONFIRM. L'étude CONFIRM est conçue pour générer des données supplémentaires garantissant la sécurité et l'efficacité du produit de la société, AGN1 Local Osteo-EnhancementRiassunto: AgNovos Healthcare completa l’arruolamento per lo studio clinico CONFIRM
NEW YORK--(BUSINESS WIRE)--AgNovos Healthcare, un’azienda che sviluppa nuove terapie di medicina rigenerativa basate su una tecnologia brevettata di costruzione ossea per affrontare bisogni non soddisfatti nel trattamento delle malattie ossee, oggi ha annunciato di avere completato l’arruolamento per lo studio clinico CONFIRM, concepito per produrre ulteriori dati a supporto della sicurezza e dell’efficacia del suo prodotto AGN1 LOEP (Local Osteo-Enhancement Procedure) quando utilizzato su donnSamenvatting: AgNovos Healthcare voltooit inschrijving voor CONFIRM klinische studie
NEW YORK--(BUSINESS WIRE)--AgNovos Healthcare, een ontwikkelaar van nieuwe therapieën die gebruik maakt van gepatenteerde, botopbouwende technologie en regeneratieve geneeskunde om onvervulde behoeften bij de behandeling van botziekte aan te pakken, kondigde vandaag de voltooiing aan van de rekrutering voor het CONFIRM-onderzoek. CONFIRM is ontworpen om aanvullende gegevens te genereren ter ondersteuning van de veiligheid en werkzaamheid van het AGN1 Local Osteo-Enhancement Procedure (LOEP) pro
Top Business Services Companies
Frequently Asked Questions Regarding AgNovos Bioscience
AgNovos Healthcare is a developer of new therapies that leverage proprietary, bone-building technology and regenerative medicine to address unmet needs in the treatment of bone disease. AgNovos Healthcare is privately held and has its corporate headquarters in New York City with manufacturing, research & development, and corporate support services... Read More